InvestorsHub Logo
Followers 4
Posts 862
Boards Moderated 0
Alias Born 03/06/2014

Re: None

Sunday, 01/31/2021 7:23:51 PM

Sunday, January 31, 2021 7:23:51 PM

Post# of 1716
Quick comparison of Cannabix and Lifeloc:

Cannabix has a current market cap of approx. $197 Million (110,124,104 shares outstanding x current price $1.79/share)

Lifeloc has a current market cap of approx. $7.3 Million (2,454,116 shares outstanding x current price $3.00/share)

The market values Cannabix at over 26 times that of Lifeloc.

They both have a Drug Detection Device patent as shown here:

Cannabix - https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2887841/summary.html

Lifeloc - https://uspto.report/patent/app/20160061807

I have always been of the opinion that Lifeloc deserves to have a value (market cap) of at least 2 x that of Cannabix.

As of Friday Cannabix is worth over 26 x that of Lifeloc and I find this absurd. They both have Drug Detection patents and they both are targeting an end of year roll out for their respective marijuana breathalyzers.

Even if Lifeloc were to just be valued at the same valuation as Cannabix, LCTC would trade at $80/share. If Lifeloc were to be valued at twice that of Cannabix (where I believe it would be fairly valued) it would trade at $160/share.

Some may think these numbers are wildly unattainable but if we had the right management team in place, we could easily see these stock prices.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTC News